Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center

NCT ID: NCT02959632

Last Updated: 2021-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-30

Study Completion Date

2020-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the common symptoms leading to an Animal Assisted Therapy consult, and to measure its (AAT) influence on the symptoms and feelings of hospitalized patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Animal Assisted Therapy is being provided by the Caring Canines program and is formally available to patients by referrals. In this study, we would like to capture why patients are being referred and to measure the influence of AAT on the symptoms and feelings of patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospitalized Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving AAT

Hospitalized patients receiving Animal Assisted Therapy (AAT).

Animal Assisted Therapy (Pet Visit) will be provided to the hospitalized patients.

Group Type EXPERIMENTAL

Animal Assisted Therapy

Intervention Type BEHAVIORAL

Animal Assisted Therapy is the program where a pet, usually dog will visit and interact with the patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Animal Assisted Therapy

Animal Assisted Therapy is the program where a pet, usually dog will visit and interact with the patients.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted to St Mary's or Methodist Hospital and subsequently referred for AAT.
* Subjects undergoing Animal Assisted Therapy as part of their standard care.
* Patients 18-80 years of age.
* Patients who are able to read and answer pre and post intervention survey questionnaire and satisfaction survey.


* Care team members of the study participants.
* 18-80 years of age.
* Who are able to read and answer pre and post intervention survey questionnaire and satisfaction survey.

Exclusion Criteria

* Patients with diagnoses of bipolar disorder, schizophrenia or dementia.
* Unable to give consent.
* Pregnant women (as verbalized by participant).


* Care team members of the study participants who do not want to participate.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ying Ying (Christina) Chen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brent A Bauer, MD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16-007730

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Testing the Efficacy of ACT for Life
NCT04829682 ENROLLING_BY_INVITATION NA